{"id":15478,"date":"2026-04-07T03:49:39","date_gmt":"2026-04-07T03:49:39","guid":{"rendered":"https:\/\/zoominfinancial.com\/?p=15478"},"modified":"2026-04-07T03:49:40","modified_gmt":"2026-04-07T03:49:40","slug":"cardiff-oncology-stock-market-dismisses-onvansertibs-potential-in-colorectal-cancer","status":"publish","type":"post","link":"https:\/\/zoominfinancial.com\/?p=15478","title":{"rendered":"Cardiff Oncology Stock: Market Dismisses Onvansertib&#8217;s Potential In Colorectal Cancer"},"content":{"rendered":"<div data-test-id=\"author-root\">\n<p class=\"mb-12 text-medium-2-r text-share-text-3\">This article was written by<\/p>\n<div class=\"relative mb-12 flex justify-between\">\n<div class=\"flex\">\n<div class=\"flex shrink-0 items-center justify-center relative size-36 rounded-full\" data-test-id=\"user-pic-wrapper\"><\/div>\n<\/div>\n<p><button data-state-text=\"Following\" aria-label=\"Follow Biologics\" class=\"ihjjQ py-8 px-18 o7ZP8 ml-8 mt-0 shrink-0 self-baseline text-small-b relative inline-flex items-center justify-center select-none hover:no-underline transition-colors motion-reduce:transition-none border-black bg-black text-white hover:bg-black-70 disabled:border-transparent disabled:bg-black-20 dark:border-black-10 dark:bg-black-10 dark:text-black dark:hover:border-black-30 dark:hover:bg-black-30 dark:disabled:bg-black-30 min-h-28 border text-medium-r px-12 py-1 whitespace-nowrap break-words rounded-6 cursor-pointer\" data-test-id=\"follow-button\" type=\"button\"><span class=\"\"><span aria-hidden=\"true\" class=\"wMAFB relative flex justify-center\" data-state-placeholder=\"Following\"><span class=\"absolute\">Follow<\/span><\/span><\/span><\/button><\/p>\n<\/div>\n<div class=\"text-medium-2-r\">\n<div class=\"relative\">\n<div class=\"relative overflow-hidden\" style=\"max-height:100%\">\n<div>\n<p>Biologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working in the medical field for years. His trade focus is around innovative companies developing breakthrough therapies and\/or pharmaceuticals with catalysts for potential acquisitions.<br \/>\nHe is the leader of the investing group Compounding Healthcare. Features of the group include: Several model healthcare portfolios, a weekly newsletter, a daily watchlist, and chat for dialogue and questions. Learn more.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div data-test-id=\"content-container\">\n<p id=\"a-disclosure\"><b>Analyst\u2019s Disclosure: <\/b><span>I\/we have a beneficial long position in the shares of CRDF either through stock ownership, options, or other derivatives.<\/span><span id=\"top-business-disclosure\"> I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. <\/span><\/p>\n<p id=\"a-disclosure-more\"><strong>Seeking Alpha&#8217;s Disclosure:<\/strong> Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.<\/p>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/seekingalpha.com\/article\/4888793-cardiff-oncology-stock-market-dismisses-onvansertib-potential-breakthrough-colorectal-cancer?source=feed_all_articles\" target=\"_blank\" rel=\"noopener\" rel=\"nofollow\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>This article was written by Follow Biologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies&#8230;<\/p>\n","protected":false},"author":1,"featured_media":15479,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":{"0":"post-15478","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cardiff Oncology Stock: Market Dismisses Onvansertib&#039;s Potential In Colorectal Cancer | ZoomInFinancial<\/title>\n<meta name=\"description\" content=\"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zoominfinancial.com\/?p=15478\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cardiff Oncology Stock: Market Dismisses Onvansertib&#039;s Potential In Colorectal Cancer | ZoomInFinancial\" \/>\n<meta property=\"og:description\" content=\"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zoominfinancial.com\/?p=15478\" \/>\n<meta property=\"og:site_name\" content=\"ZoomInFinancial\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T03:49:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-07T03:49:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2026\/04\/image_2202939605.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478#article\",\"isPartOf\":{\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/zoominfinancial.com\/#\/schema\/person\/27fc0bac212db836c2d4246d4037414b\"},\"headline\":\"Cardiff Oncology Stock: Market Dismisses Onvansertib&#8217;s Potential In Colorectal Cancer\",\"datePublished\":\"2026-04-07T03:49:39+00:00\",\"dateModified\":\"2026-04-07T03:49:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/zoominfinancial.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/zoominfinancial.com\/?p=15478#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478\",\"url\":\"https:\/\/zoominfinancial.com\/?p=15478\",\"name\":\"Cardiff Oncology Stock: Market Dismisses Onvansertib's Potential In Colorectal Cancer | ZoomInFinancial\",\"isPartOf\":{\"@id\":\"https:\/\/zoominfinancial.com\/#website\"},\"datePublished\":\"2026-04-07T03:49:39+00:00\",\"dateModified\":\"2026-04-07T03:49:40+00:00\",\"description\":\"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working\",\"breadcrumb\":{\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zoominfinancial.com\/?p=15478\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zoominfinancial.com\/?p=15478#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/zoominfinancial.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cardiff Oncology Stock: Market Dismisses Onvansertib&#8217;s Potential In Colorectal Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zoominfinancial.com\/#website\",\"url\":\"https:\/\/zoominfinancial.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/zoominfinancial.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zoominfinancial.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/zoominfinancial.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/zoominfinancial.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/zoominfinancial.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/zoominfinancial.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/zoominfinancial.com\/#\/schema\/person\/27fc0bac212db836c2d4246d4037414b\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/zoominfinancial.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/zoominfinancial.com\"],\"url\":\"https:\/\/zoominfinancial.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cardiff Oncology Stock: Market Dismisses Onvansertib's Potential In Colorectal Cancer | ZoomInFinancial","description":"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zoominfinancial.com\/?p=15478","og_locale":"en_US","og_type":"article","og_title":"Cardiff Oncology Stock: Market Dismisses Onvansertib's Potential In Colorectal Cancer | ZoomInFinancial","og_description":"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working","og_url":"https:\/\/zoominfinancial.com\/?p=15478","og_site_name":"ZoomInFinancial","article_published_time":"2026-04-07T03:49:39+00:00","article_modified_time":"2026-04-07T03:49:40+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2026\/04\/image_2202939605.jpg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/zoominfinancial.com\/?p=15478#article","isPartOf":{"@id":"https:\/\/zoominfinancial.com\/?p=15478"},"author":{"name":"Press Room","@id":"https:\/\/zoominfinancial.com\/#\/schema\/person\/27fc0bac212db836c2d4246d4037414b"},"headline":"Cardiff Oncology Stock: Market Dismisses Onvansertib&#8217;s Potential In Colorectal Cancer","datePublished":"2026-04-07T03:49:39+00:00","dateModified":"2026-04-07T03:49:40+00:00","mainEntityOfPage":{"@id":"https:\/\/zoominfinancial.com\/?p=15478"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/zoominfinancial.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/zoominfinancial.com\/?p=15478#respond"]}]},{"@type":"WebPage","@id":"https:\/\/zoominfinancial.com\/?p=15478","url":"https:\/\/zoominfinancial.com\/?p=15478","name":"Cardiff Oncology Stock: Market Dismisses Onvansertib's Potential In Colorectal Cancer | ZoomInFinancial","isPartOf":{"@id":"https:\/\/zoominfinancial.com\/#website"},"datePublished":"2026-04-07T03:49:39+00:00","dateModified":"2026-04-07T03:49:40+00:00","description":"This article was written byFollowBiologics is a full-time healthcare investor who developed a passion for biotech and life saving therapies after working","breadcrumb":{"@id":"https:\/\/zoominfinancial.com\/?p=15478#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zoominfinancial.com\/?p=15478"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/zoominfinancial.com\/?p=15478#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/zoominfinancial.com\/"},{"@type":"ListItem","position":2,"name":"Cardiff Oncology Stock: Market Dismisses Onvansertib&#8217;s Potential In Colorectal Cancer"}]},{"@type":"WebSite","@id":"https:\/\/zoominfinancial.com\/#website","url":"https:\/\/zoominfinancial.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/zoominfinancial.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zoominfinancial.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/zoominfinancial.com\/#organization","name":"Fintech Advance","url":"https:\/\/zoominfinancial.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/zoominfinancial.com\/#\/schema\/logo\/image\/","url":"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/zoominfinancial.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/zoominfinancial.com\/#\/schema\/person\/27fc0bac212db836c2d4246d4037414b","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/zoominfinancial.com\/#\/schema\/person\/image\/","url":"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/zoominfinancial.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/zoominfinancial.com"],"url":"https:\/\/zoominfinancial.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/posts\/15478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=15478"}],"version-history":[{"count":1,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/posts\/15478\/revisions"}],"predecessor-version":[{"id":15480,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/posts\/15478\/revisions\/15480"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=\/wp\/v2\/media\/15479"}],"wp:attachment":[{"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=15478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=15478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zoominfinancial.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=15478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}